The primary indication and outcome for all four studies was diabetes and glycemic control, respectively; two of the studies compared insulin glargine versus insulin detemir, while the remaining two studies evaluated different methods of insulin administration (e.g., wearable insulin delivery compared with multiple daily injections; data not shown). Here, INS is linked to diabetes mellitus.